Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Dusu Qing pellets in elderly community-acquired pneumonia
ChiCTR-IPR-14005357Phase 2Recruiting
- Sponsor
- Fujian Academy of Traditional Chinese Medicine
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Dusu Qing pellets in community-acquired pneumonia (CAP) (2 arms), sponsored by Fujian Academy of Traditional Chinese Medicine. Primary endpoints: Symptoms disappeared rate at day 7 and Time to disappearance of single main symptoms. Started May 2014; status: recruiting.
02
Drugs
Dusu Qing pellets
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR-IPR-14005357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005357.